Injective Futures Touch Down in the US of A—Now Everyone's Squinting at the ETF Horizon

Bitnomial has rolled out monthly futures contracts for Injective (INJ), marking the first US-regulated derivatives product for the Web3 financial ecosystem's native token. The contracts settle in INJ with monthly expiries, letting traders get price exposure without holding the underlying asset. Users can margin in crypto or cold hard US dollars through Bitnomial's clearinghouse. Because apparently, some people want to bet on INJ price action without actually owning any INJ—like ordering food delivery but pretending you're on a diet.

But here's the kicker: this listing kicks off a six-month track record that could pave the way for a spot ETF under SEC listing rules. In July, Canary Capital already filed for a staked INJ ETF, with Cboe BZX Exchange submitting a corresponding rule change to the regulator. The SEC is basically being asked to let another altcoin ETF through the velvet rope, and everyone's pretending they haven't noticed the pattern after Bitcoin and Ethereum basically said "we're too big to ignore."

Institutional clients can jump in right now, while retail traders will get access via Bitnomial's Botanical platform in the coming weeks. The exchange also has plans to add perpetual futures and options tied to INJ. Because monthly expiries weren't enough to satisfy the degens—now they want to never close their positions like that one friend who still hasn't closed their 2021 leveraged long.

Injective runs on a Layer 1 blockchain built for financial applications, featuring an onchain order book and cross-chain connectivity to networks including Ethereum and Solana. Bitnomial operates as a CFTC-regulated derivatives exchange with its own trading venue, clearinghouse, and brokerage. It's basically the adult version of trading crypto—regulated, boring, and exactly what institutions need to stop pretending they're not in this space.

This isn't Bitnomial's first altcoin rodeo—back in January, the exchange launched monthly futures for Aptos (APT), another first for that token in US-regulated markets. They learned from Aptos what works and what doesn't, which probably means slightly better risk management and definitely better party planning for launch day.

The path to listing altcoin futures hasn't always been smooth. In August 2024, Bitnomial tried to list XRP futures through CFTC self-certification, but the SEC got involved, arguing the contracts might require securities exchange registration. Bitnomial fired back with a lawsuit in October 2025, then dropped it in March and launched regulated XRP futures later that month, citing evolving SEC policy. The SEC said "maybe securities," Bitnomial said "see you in court," everyone took a breath, and then the SEC quietly changed its mind like someone pretending they never suggested the bad idea in the first place.

Other players have been expanding too. Coinbase launched CFTC-regulated futures for Bitcoin and Ether for institutional clients in June 2023, opened up retail-sized contracts in May 2025, and introduced 24/7 trading. Meanwhile, Kraken snagged futures platform NinjaTrader for about $1.5 billion in May, gaining a CFTC-registered Futures Commission Merchant and expanding into regulated derivatives. It's like watching everyone rush to build the same castle, except instead of sand, it's regulatory compliance, and instead of waves, it's the SEC.